Skip to main content
SpringerLink
Log in

Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study

  • Original Paper
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

Abstract

Drug-eluting stents (DES) have reduced the rate of restenosis but recent studies have raised concern over the risk of late stent thrombosis (LST). Incomplete stent endothelialization and delayed vascular healing have been associated with LST. The titanium-nitride-oxide coated bio-active stent (BAS) has shown promising results in patients with acute coronary syndromes, but there is little long-term optical coherence tomography (OCT) data comparing BAS with DES. The TITAX-AMI trial is a prospective, randomized, multicenter trial comparing BAS to paclitaxel-eluting stent (PES) in 425 patients with acute myocardial infarction. A total of 18 patients (9 per group) with no major cardiac events during follow-up, were enrolled in this substudy >36 months (mean 47 months) after stent implantation. Quantitative coronary angiography was performed and stent strut endothelialization and vascular healing were assessed with OCT. The binary stent strut coverage was significantly higher in the BAS group compared with the PES group (99.6 vs. 89.2%, p < 0.001) and there were less malapposed struts in the BAS group (0.2 vs. 13.8%, respectively, p < 0.001). The neointimal hyperplasia (NIH) thickness (266 ± 166 vs. 126 μm ± 126 μm, p < 0.001) and percentage of NIH area (26.2 vs. 7.6%, p < 0.001) were greater in the BAS group than in the PES group. Late incomplete endothelialization was not uncommon after PES implantation. Stents in the BAS group were completely endothelialized. This difference may contribute to the more common LST after PES implantation in the TITAX-AMI trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nordmann AJ, Briel M, Bucher HC (2006) Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27:2784–2814

    Article  PubMed  CAS  Google Scholar 

  2. Stone GW, Moses JW, Ellis SG et al (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356:998–1008

    Article  PubMed  CAS  Google Scholar 

  3. Lagerqvist B, James SK, Stenestrand U et al (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009–1019

    Article  PubMed  CAS  Google Scholar 

  4. Camenzind E, Steg PG, Wijns W (2007) Stent thrombosis late after implantation of first generation drug-eluting stents: a cause for concern. Circulation 115:1440–1455

    Article  PubMed  Google Scholar 

  5. Finn AV, Joner M, Nakazawa G et al (2007) Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115:2435–2441

    Article  PubMed  Google Scholar 

  6. Windecker S, Simon R, Lins M et al (2005) Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization The TiNOX trial. Circulation 111:2617–2622

    Article  PubMed  CAS  Google Scholar 

  7. Mosseri M, Miller H, Tamari I et al (2006) The titanium-NO stent: results of a multicenter registry. Eurointervention 2:192–196

    PubMed  Google Scholar 

  8. Giraud-Sauveur Y (2007) Titan 2 bio-active stent (BAS) with titanium-NO. Eurointervention 3:526–528

    Article  Google Scholar 

  9. Karjalainen PP, Ylitalo A, Airaksinen JKE (2006) Real world experience with the TITAN stent: a 9-month follow-up report from the Titan PORI registry. Eurointervention 2:187–191

    PubMed  Google Scholar 

  10. Karjalainen PP, Annala A-P, Ylitalo A, Vahlberg T, Airaksinen KE (2010) Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population. Int J Cardiol 114:42–46

    Article  Google Scholar 

  11. Karjalainen PP, Ylitalo A, Niemelä M et al (2008) Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-month follow-up report from the TITAX AMI trial. Eurointervention 4:232–241

    Article  Google Scholar 

  12. Karjalainen PP, Ylitalo A, Niemelä M et al (2009) Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction. Ann Med 41:599–607

    Article  PubMed  CAS  Google Scholar 

  13. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI (2009) Intracoronary optical coherence tomography: a comprehensive review. Clinical and research applications. JACC Cardiovasc Interv 2:1035–1046

    Article  PubMed  Google Scholar 

  14. Fan C, Kim J-S, Lee JM et al (2010) Different vascular healing patterns with various drug-eluting stents in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: optical coherence tomographic findings. Am J Cardiol 105:972–976

    Article  PubMed  CAS  Google Scholar 

  15. Kim J-S, Fan C, Choi D, Jang I-K, Lee JM, Kim TH et al (2009) Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study. Int J Cardiol. doi:10.1016/j.ijcard.2009.07.012

    Google Scholar 

  16. Guagliumi G, Musumeci G, Sirbu V et al (2010) Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 3:521–529

    Google Scholar 

  17. Miyoshi N, Shite J, Sinke T et al (2010) Comparison by optical coherence tomography of paclitaxel-eluting stents with sirolimus-eluting stents implanted in one coronary artery in one procedure; 6-month follow-up. Circ J 74:903–908

    Article  PubMed  Google Scholar 

  18. Motreff P, Souteyrand G, Levesque S et al (2009) Comparative analysis of neointimal coverage with paclitaxel and zotarolimus drug-eluting stents, using optical coherence tomography 6 months after implantation. Arch Cardiovasc Dis 102:617–624

    Article  PubMed  Google Scholar 

  19. Kim J-S, Kim J-S, Kim TH et al (2010) Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation. Circ J 74:320–326

    Article  PubMed  Google Scholar 

  20. Guagliumi G, Costa MA, Sirbu V et al (2011) Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial. Circulation 123:274–281

    Article  PubMed  CAS  Google Scholar 

  21. Räber L, Garcia Garcia HM, Baumgartner S, et al (2011) Vascular healing response five years after implantation of first generation DES: the SIRTAX LATE optical coherence study. Abstr Eurointerv 7(Suppl M):194

    Google Scholar 

  22. Kim J-S, Hong M-K, Fan C et al (2010) Intracoronary thrombus formation after drug-eluting stents implantation: optical coherence tomographic study. Am Heart J 159:278–283

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by grants (K.E.J.A) from the Finnish Foundation for Cardiovascular Research, Helsinki, Finland.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Heart Center, Satakunta Central Hospital, Sairaalantie 3, 28500, Pori, Finland

    Tuomas Lehtinen, Antti Ylitalo & Pasi P. Karjalainen

  2. Department of Medicine, Turku University Hospital, Kiinamyllynkatu 4-8, 20520, Turku, Finland

    Tuomas Lehtinen & K. E. Juhani Airaksinen

Authors
  1. Tuomas Lehtinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. E. Juhani Airaksinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antti Ylitalo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pasi P. Karjalainen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pasi P. Karjalainen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lehtinen, T., Airaksinen, K.E.J., Ylitalo, A. et al. Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study. Int J Cardiovasc Imaging 28, 1859–1866 (2012). https://doi.org/10.1007/s10554-012-0032-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-012-0032-6

Keywords

Search

Navigation